Tipoline approved in China: the world's first drug for the treatment of OSA, how it will change the fate of hundreds of millions of patients

OSA—A Health Threat Hidden in Sleep

Obstructive sleep apnea (OSA) is a chronic disease characterized by recurrent nocturnal breathing apnea, affecting approximately 425 million people worldwide, including as many as 176 million in China. For a long time, OSA treatment has relied on weight loss and CPAP machines, but patient adherence is poor and efficacy is limited. Recently, Eli Lilly's tirzepatide... Approved by the China Food and Drug Administration, it has become the first and only drug in China for the treatment of obesity-related OSA in adults, marking a new stage in OSA treatment.

 

The dangers of OSA: a health crisis far exceeding "snoring"

OSA is not just about snoring at night; its harm affects multiple systems throughout the body.

● Cardiovascular risk : OSA patients have a 4.33 times higher risk of stroke and a 1.98 times higher mortality rate than the general population.

● Metabolic effects : Closely related to obesity, diabetes, and hypertension.

● Decreased quality of life : daytime sleepiness, cognitive decline, and even increased risk of traffic accidents.

Traditional treatment methods include continuous positive airway pressure (PAP). The patient needs to wear a mask at night, and weight loss requires long-term self-discipline, which many patients find difficult to maintain, leading to a continuous deterioration of their condition.

 

Telpoeptide: A Breakthrough in the World's First OSA Treatment

1. International Recognition: FDA First, China Follows

In December 2023, the U.S. FDA approved telpoitide for the treatment of OSA, making it the world's first drug for this indication. In 2024, the China Food and Drug Administration (CFDA) officially approved its marketing based on data from the SURMOUNT-OSA Phase 3 clinical trial .

2. Clinical trial data: Significantly improves sleep apnea

● Study design : 469 patients with moderate to severe OSA were divided into a group that did not receive PAP treatment and a group that was currently receiving PAP treatment.

● Therapeutic results :

○ Reduced Apnea Index (AHI) : The telpokines group experienced a reduction of 25 breaths/hour, which was 4.8 to 5.3 times that of the placebo group.

Symptom relief rate : 43% of patients who did not use PAP and 52% of patients who received combined PAP treatment achieved complete remission or mild OSA, compared to only 15% in the placebo group.

○ Weight loss effect : The average weight loss was 17.7%~19.6%, far exceeding the 1.6%~2.3% of the placebo group.

3. Treatment advantages: High compliance, dual benefits

● One injection per week eliminates the need for nighttime ventilator use, significantly improving patient compliance.

● It combines weight loss with OSA improvement , and is especially suitable for obesity-related OSA patients.

 

Telpoeptide vs. Traditional Treatments: Why It's Becoming a New Option

Treatment methods	Advantages	limitation
Telpoeptide	One injection per week, high remission rate, significant weight loss effect.	Prescription required, high price
PAP ventilator	Directly improve nighttime hypoxia	Uncomfortable to wear, low long-term compliance
lose weight	Improve overall health	Slow to take effect, limited effectiveness for severely ill patients

 

 

OSA Treatment Enters a New Era

A senior vice president at Eli Lilly stated, "The approval of telpotetide fills a gap in OSA drug treatment, providing a new solution for nearly 200 million Chinese patients." Looking ahead, the focus will be on "medication + lifestyle intervention." It may become the new standard of care for OSA.

 

From incurable to precision medicine, OSA patients are seeing new hope.

The launch of telpotetide not only rewrote the history of OSA treatment but also provided patients with a more convenient and efficient option. With its widespread clinical application, OSA management will enter a new phase, helping hundreds of millions of people regain healthy sleep.

🏆 Asakusa Cosmetics provides you with

✔️ Authentic tesipatide (global cold chain shipping)

✔️ Hospital prescription

✔️ Online doctor consultation

✔️ Pharmacist's Medication Instructions

✔️ Comprehensive after-sales tracking service